Gene/SNP | Colon cancer | Rectal cancer | ||||
---|---|---|---|---|---|---|
Case/Cont | ORa (95% CI) | ORb (95% CI) | Case/Cont | ORa (95% CI) | ORb (95% CI) | |
SOD2 | ||||||
RS4880 | ||||||
AA | 179/318 | 1.0 | 1.0 | 164/318 | 1.0 | 1.0 |
GA + GG | 43/81 | 0.44 (0.11–1.71) | 0.58 (0.14–2.34) | 36/81 | 0.91 (0.16–5.24) | 0.90 (0.15–5.37) |
SELS | ||||||
RS34713741 | ||||||
CC | 86/151 | 1.0 | 1.0 | 65/151 | 1.0 | 1.0 |
CT | 116/200 | 1.00 (0.71–1.42) | 0.90 (0.62–1.31) | 112/200 | 1.29 (0.88–1.87) | 1.32 (0.88–1.97) |
TT | 13/39 | 0.58 (0.29–1.15) | 0.52 (0.25–1.06) | 20/39 | 1.16 (0.63–2.16) | 1.12 (0.58–5.18) |
P for trend | 0.284 | 0.128 | 0.335 | 0.402 | ||
SEPP1 | ||||||
RS7579 | ||||||
CC | 94/192 | 1.0 | 1.0 | 101/192 | 1.0 | 1.0 |
CT | 82/134 | 1.23 (0.85–1.78) | 1.18 (0.80–1.76) | 68/134 | 0.91 (0.62–1.33) | 0.93 (0.62–1.40) |
TT | 19/41 | 0.94 (0.52–1.71) | 0.90 (0.47–1.71) | 13/41 | 0.56 (0.28–1.09) | 0.56 (0.27–1.15) |
P for trend | 0.703 | 0.772 | 0.126 | 0.212 | ||
SEP15 | ||||||
RS5845 | ||||||
GG | 216/390 | 1.0 | 1.0 | 189/390 | 1.0 | 1.0 |
GA | 8/12 | 1.20 (0.48–2.99) | 1.41 (0.52–3.83) | 12/12 | 2.01 (0.88–4.58) | 2.47 (0.99–6.19) |
P | 0.695 | 0.506 | 0.098 | 0.052 | ||
SEP15 | ||||||
RS5859 | ||||||
CC | 217/390 | 1.0 | 1.0 | 187/390 | 1.0 | 1.0 |
CT | 8/12 | 1.19 (0.48–2.97) | 1.40 (0.51–3.81) | 12/12 | 2.03 (0.89–4.63) | 2.51 (1.00–6.28) |
P | 0.702 | 0.513 | 0.093 | 0.049 | ||
GPX4 | ||||||
RS713041 | ||||||
CC | 103/150 | 1.0 | 1.0 | 81/150 | 1.0 | 1.0 |
CT | 86/184 | 0.68 (0.48–0.97) | 0.79 (0.54–1.16) | 85/184 | 0.86 (0.59–1.24) | 0.91 (0.61–1.37) |
TT | 28/48 | 0.85 (0.50–1.44) | 1.04 (0.58–1.87) | 26/48 | 0.98 (0.56–1.70) | 1.19 (0.65–2.15) |
P for trend | 0.17 | 0.673 | 0.692 | 0.803 | ||
GPX1 | ||||||
RS1050450 | ||||||
CC | 165/293 | 1.0 | 1.0 | 160/293 | 1.0 | 1.0 |
CT + TT | 35/67 | 0.93 (0.59–1.46) | 1.13 (0.70–1.83) | 25/67 | 0.69 (0.42–1.14) | 0.78 (0.45–1.32) |